Latest Technology News

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.

Integrated Research Limited reported a modest revenue dip and significant profit declines in FY25 as it pivots to a product-led growth strategy focused on AI-powered observability solutions and hybrid pricing models.

St George Mining reports outstanding high-grade rare earth and niobium assay results from its Araxá Project in Brazil, signaling a significant resource expansion and upgrade. Ongoing drilling suggests the deposit remains open in all directions, reinforcing Araxá’s status as a world-class asset.

Trek Metals has raised $1 million through a strategic placement to fast-track exploration at its Christmas Creek manganese project, with investor Andrew Reece committing $500,000 and joining the board.

BPM Minerals reports outstanding high-grade rare earth element assays from its Durack Project in Western Australia, highlighting the potential for a major monazite-hosted REE deposit. The discovery aligns with growing global demand and Australian government support for critical minerals.

Power Minerals Limited has reported further high-grade niobium and rare earth element results from its Santa Anna project in Brazil, setting the stage for a significant 10,000m drilling campaign aimed at delivering a maiden resource estimate in early 2026.

ClearVue Technologies has secured an A$881k Australian Government R&D rebate and used part of it to retire a A$409k loan, strengthening its financial position as it advances its solar glass technology.

Jcurve Solutions has updated its revenue recognition policy for its ERP subscription licenses, shifting from point-in-time to over-time recognition, leading to restated FY25 financials and enhanced transparency.

Voltaic Strategic Resources confirms two significant rare earth oxide and gallium mineral systems at its Paddys Well Project in Western Australia, revealing broad high-grade intercepts and strong exploration potential.

DroneShield Limited reaffirms strong business fundamentals with record revenues in 2025, while addressing recent media reports and initiating an independent governance review.

Island Pharmaceuticals has secured membership in the Medical Countermeasures Coalition, positioning its antiviral Galidesivir for critical US government stockpiling and regulatory milestones.

New data reveals that Thoroughbred racehorses free from oxidative stress are significantly more likely to win or place, spotlighting OxiDx’s patented biomarker test as a game-changer in equine performance and welfare.